These data suggest that reductions in both CD36-mediated hepatic free fatty acid uptake and CCL2-associated liver inflammation ameliorate MCD-induced NASH in Mettl3-HOE mice. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatohepatitis.